TD Cowen and William Blair are acting as joint book-running managers for the proposed offering. Craig-Hallum is acting as lead manager. Stephens Inc. and Roth Capital Partners are acting as ...
Jefferies, Leerink Partners, Morgan Stanley and Cantor are acting as joint book-running managers for the offering. LifeSci Capital, BMO Capital Markets and H.C. Wainwright & Co. are acting as ...
Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that further to its announcement on September 3, 2026 and following the completion of customary closing conditions ...
TD Cowen and William Blair are acting as joint book-running managers for the proposed offering.
A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at About CeriBell, Inc. Ceribell is a medical technology company focused on ...
CLL/SLL is a clonal proliferative malignancy of B lymphocytes that predominantly affects older adults, with more than 100,000 new cases worldwide each year. 1 In recent years, the incidence of CLL/SLL ...
Set forth below are certain preliminary unaudited financial results for the three months ended September 30, 2026 and as of September 30, 2026: Revenue for the three months ended September 30, 2026 is ...
(Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in ...
Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic ...
BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap investor conference in Toronto, Ontario from October 27 th to October 29 th, 2026 at ...
LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, announces that it will report financial results for the three and nine months ended September 30, 2026, ...
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 a.m. ET on November 5, 2026. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results